{"product_id":"gynecologic-pathology-diagnosis-and-management-harry-c-harvey-9798198136168","title":"Gynecologic Pathology Diagnosis and Management: Evidence-Based Textbook Covering WHO 2020 Classification, Molecular Subtyping, \u0026 FIGO 2023 Staging for","description":"\u003cp\u003eEvery specimen you sign out in gynecologic pathology is a clinical decision - and the accuracy of that decision determines whether your patient receives the right surgery, the right chemotherapy, or the right conversation with a genetic counselor.\u003c\/p\u003e\u003cp\u003eA missed STIC on a routine RRSO, a p53 result reported without its pattern, a Krukenberg tumor called a primary ovarian carcinoma - these are not rare edge cases, they are the everyday consequences of pathology practiced without the full morphology-to-management chain in view.\u003c\/p\u003e\u003cp\u003eThis book builds that chain for you, entity by entity, specimen by specimen, so that every result you issue connects directly to a clinical outcome you can defend.\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- The complete FIGO 2023 endometrial staging framework\u003c\/b\u003e - apply molecular modifiers, LVSI quantification, and p53abn Stage IIC assignment to every hysterectomy you sign\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- BRCA\/HRD testing that starts in your laboratory\u003c\/b\u003e - know exactly which results open the olaparib, niraparib, and dostarlimab pathways before the oncologist calls\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- The MMR IHC reflex algorithm in full\u003c\/b\u003e - from loss pattern to MLH1 methylation to germline testing recommendation written into your report\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- Leiomyosarcoma vs. symplastic leiomyoma\u003c\/b\u003e - the Stanford three-criterion system applied case by case so you stop over-diagnosing and stop missing the real ones\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- The Translation System built into every chapter\u003c\/b\u003e - five-part morphology-to-management callouts that take you from H\u0026amp;E to IHC to molecular test to FIGO stage to treatment in a single structured sequence\u003c\/p\u003e\u003cp\u003e\u003cb\u003e- Primary site determination for every ambiguous mass\u003c\/b\u003e - Krukenberg, peritoneal mesothelioma, metastatic lobular carcinoma - with the IHC panel that resolves each one\u003c\/p\u003e\u003cp\u003eThis book is written for gynecologic pathologists, surgical pathology trainees, and pathology-engaged gynecologic oncologists who want their reports to do more than describe findings.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Harry C. Harvey\u003cbr\u003e\u003cb\u003eISBN-13:\u003c\/b\u003e 9798198136168\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Independently Published\u003cbr\u003e\u003cb\u003eLanguage:\u003c\/b\u003e English\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 05\/22\/2026\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 418\u003cbr\u003e\u003cb\u003eFormat:\u003c\/b\u003e Paperback\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 2.12lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 11.00h x 8.50w x 0.85d","brand":"Harry C. Harvey","offers":[{"title":"Paperback","offer_id":48801577533695,"sku":"9798198136168","price":250.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.whiterainbookhouse.com\/products\/gynecologic-pathology-diagnosis-and-management-harry-c-harvey-9798198136168","provider":"WR Book House","version":"1.0","type":"link"}